FDA+ roundup: FDA continues to loosen standard of evidence for novel drug approvals — JAMA research letter
The FDA is continuing to lower the bar of its approval standards for novel drug applications, according to a new analysis of evidence on approvals …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
